Suppression of an amyloid β-peptide-mediated calcium channel response by a secreted β-amyloid precursor protein

Neuroscience

Volumn 95, Issue 1, 1999, Pages 1-4

  Li, W Y ^a   Butler, J P ^a   Hale, J E ^a   McClure, D B ^a   Little, S P ^a   Czilli, D L ^a   Simmons, L K ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

amyloid precursor protein; amyloid protein; A toxicity neuroprotection; Alzheimer's Disease; Calcium channel

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CALCIUM CHANNEL;

ALZHEIMER DISEASE; ARTICLE; CHANNEL GATING; HUMAN; NEUROTOXICITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CALCIUM CHANNELS; CELLS, CULTURED; CYCLIC GMP; HIPPOCAMPUS; PATCH-CLAMP TECHNIQUES; PEPTIDE FRAGMENTS; RATS;

EID: 0032704781     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00479-0     Document Type: Article

References (21)

1. Barger S.W., Fiscus R.R., Ruth P., Hofman F., Mattson M.P. Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β-amyloid precursor. J. Neurochem. 64:1994;2087-2095.
2. Burdick D., Soreghan B., Kwon M., Kosmoski L., Knauer M., Henschen A., Yates L., Cotman C., Glabe C. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267:1992;546-554.
3. Checler F. Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65:1995;1431-1441.
4. Esch F.S., Keim P.S., Beattie E.C., Blacher R.M., Culwell A.K., Oltersdorf T., McClure D., Ward P.J. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science. 248:1990;1122-1124.
5. + channels and suppression of neuronal activity by secreted β-amyloid precursor protein. Nature. 379:1996;7478.
6. Goodman Y., Mattson M.P. Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide induced oxidative injury. Expl Neurol. 128:1994;112.
7. Katzman R. Alzheimer's disease. New Engl. J. Med. 314:1986;964-972.
8. Knops J., Johnson-Wood K., Schenk D.B., Sinha S., Lieberburg I., McConlogue L. Isolation of baculovirus secreted and full-length β-amyloid precursor protein. J. biol. Chem. 266:1991;7285-7290.
9. Li W.Y., Czilli D.L., Simmons L.K. Neuronal membrane conductance activated by amyloid βpeptide: importance of peptide conformation. Brain Res. 682:1995;207-211.
10. Lowery D.E., Pastenack J.M., Gonzales-De Whitt J.M., Zurcher-Neely P.A., Tomich C.S., Altman R.A., Fairbanks M.B., Heinrikson R.B., Younkin S.G. Alzheimer's amyloid precursor protein produced by recombinant baculovirus expression: proteolytic processing and protease inhibitory properties. J. biol. Chem. 266:1991;2-19850.
11. Mattson M.P., Cheng B., Culwell A.R., Esch F.S., Lieberburg I., Rydel R.E. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron. 10:1993;243-254.
12. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E. β Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;376-389.
13. Mattson M.P., Tomaselli K.J., Rydel R.E. Calcium-destabilizing and neurodegeneration effects of aggregated β-amyloid peptides are attenuated by basic FGF. Brain Res. 621:1993;35-49.
14. Meziane H., Dodart J.C., Mathis C., Little S., Clemens L., Paul S.M., Ungerer A. Memory enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice. Proc. natn. Acad. Sci U.S.A. 1998.
15. Oltersdorf T., Fritz L.C., Schenk D.B., Lieberburg L., Johnson-Wood K.L., Beattie E.C., Ward P.J., Blacher R.W., Dovey H.F., Sinha S. The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature. 341:1989;144-147.
16. Pike C.L., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13:1993;1676-1687.
17. Selkoe D.J. Alzheimer's disease: a central role for amyloid. J. Neuropath. exp. Neurol. 53:1994;438-447.
18. th Annual Meeting for the Society of Neuroscience Abstracts. 21:1995;478.
19. Simmons L.K., May P.K., Tomaselli K.L., Rydel R.E., Fuson K.S., Brigham E.E., Wright S., Lieberburg L., Becker G. Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Molec. Pharmac. 45:1994;373-379.
20. Van Nostrand W.E., Wagner S., Suzuki M., Choi B.R., Farrow J.S., Geddes L.W., Cotman C.W., Cunningham D.D. Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor. Nature. 341:1989;546-549.
21. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science. 250:1990;79-282.